Journal of Neuro-Oncology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 24, 2024
Abstract
Purpose
Mexico
has
the
second
highest
incidence
of
central
and
peripheral
nervous
system
cancer
cases
in
Latin
America,
but
clinical
research
resources
to
improve
oncologic
care
are
biased
towards
high-income
countries.
We
carried
out
a
retrospective
study
identify
sociodemographic
factors
associated
with
more
severe
presentation
among
surgical
neuro-oncology
who
underwent
surgery
at
major
public
referral
hospital
City.
Methods
The
electronic
medical
record
was
reviewed
all
patients
between
January
1
December
31,
2022.
Descriptive
statistics
were
used
characterize
patient
population
outcomes;
statistical
analysis
performed
determine
association
variables
advanced
presentation.
Results
A
total
366
during
period.
median
age
48
(IQR
17–83).
majority
female
(60.1,
n
=
220),
single
(51.4%,
188),
29.2%
(
107)
endorsed
being
primary
provider
for
their
family.
number
dependents
per
4
2–50),
while
monthly
income
10269
Mexican
pesos
(MXN)
2000–13500]
travel
distance
INNN
49
km
22–174).
On
multivariate
analyses,
having
higher
increased
odds
presenting
longer
symptom
duration
p
0.01).
Divorced/separated
status
tumors
>
35mL
volume
0.04).
Primary
0.01)
average
0.03)
decreased
35mL.
Conclusions
This
is
first
recognize
that
certain
patients.
Further
studies
needed
order
decern
specific
causes
delayed
this
create
targeted
interventions
decrease
delays
care.
BMJ Open,
Journal Year:
2023,
Volume and Issue:
13(9), P. e074151 - e074151
Published: Sept. 1, 2023
This
study
aimed
to
explore
the
work
experiences
of
people
living
with
an
oligodendroglioma.This
was
a
descriptive
qualitative
study.
One-time
semi-structured
interviews
exploring
supportive
care
needs
were
conducted;
discussed
at
various
points
throughout
each
interview.
An
inductive
thematic
analysis
undertaken.Participants
recruited
across
UK
through
four
National
Health
Service
hospitals
and
Brain
Tumour
Charity
research
involvement
networks.19
grade
2
or
3
oligodendroglioma
(mean
age
52
years;
male
n=11).
At
diagnosis,
16
participants
working,
studying
1
retired.
interview
time
since
diagnosis
9.6
range
1-18
years),
seven
eight
retired
(four
on
medical
grounds)
unable
due
illness.Seven
themes
constructed:
(1)
physical
cognitive
limitations;
(2)
ability
productivity;
(3)
accommodations;
(4)
changing
roles;
(5)
attitudes
clients
coworkers;
(6)
feelings
ambitions;
(7)
financial
implications.
Fatigue,
seizures
deficits
influenced
ability.
A
stressful
environment
could
exacerbate
symptoms.
Changes
in
job
roles
often
required.
Employer
coworker
support
integral
positive
experiences.
Work
changes
result
stress
strain.This
has
highlighted,
for
first
time,
influences
this
understudied
population.
These
findings
have
implications
clinicians
employers,
when
considering
importance
rehabilitation
oligodendrogliomas,
individually
assessed
adjustments
required
accommodate
them,
should
employment
be
desired.
Neuro-Oncology Practice,
Journal Year:
2024,
Volume and Issue:
12(1), P. 87 - 99
Published: Aug. 3, 2024
Abstract
Background
Lower-grade
(WHO
grades
2–3)
gliomas
typically
affect
young
and
middle-aged
adults
exhibit
isocitrate
dehydrogenase
(IDH)
mutations.
For
such
patients,
symptoms
related
to
the
tumor
associated
treatment
contribute
morbidity
erode
quality
of
life.
With
improved
treatment,
a
better
understanding
these
effects
over
time
is
critically
needed.
Existing
data
characterizing
unmet
needs
lower-grade
glioma
patients
limited
little
consensus
exists
on
addressing
in
clinical
practice.
Methods
In
order
identify
address
focus
groups
among
caregivers
were
initially
conducted
treated
at
single
academic
center.
A
semi-structured
interview
guide
comprehensively
understand
was
then
developed.
Each
patient-defined
need
categorized
into
domains
through
qualitative
content
analysis.
parallel,
database
established
local
regional
community-based
resources
established,
dedicated
resource
specialist
provided
patient-specific
referrals
follow-up.
Results
Eighty-five
interviewed.
Median
age
41
years
median
from
diagnosis
63
months.
Approximately
68%
had
WHO
grade
2
60%
off
therapy.
Qualitative
analysis
identified
5
overarching
need:
Psychosocial;
Neurologic/Cognitive;
Lifestyle;
Financial;
Other
Medical.
At
least
one
by
71%
participants
most
common
Psychosocial
(40.7%)
Lifestyle
(34.9%).
Conclusions
Our
program
begins
frequently
survivorship
that
spanned
major
domains.
Further
research
aimed
define
warranted.
Journal of Neuro-Oncology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 24, 2024
Abstract
Purpose
Mexico
has
the
second
highest
incidence
of
central
and
peripheral
nervous
system
cancer
cases
in
Latin
America,
but
clinical
research
resources
to
improve
oncologic
care
are
biased
towards
high-income
countries.
We
carried
out
a
retrospective
study
identify
sociodemographic
factors
associated
with
more
severe
presentation
among
surgical
neuro-oncology
who
underwent
surgery
at
major
public
referral
hospital
City.
Methods
The
electronic
medical
record
was
reviewed
all
patients
between
January
1
December
31,
2022.
Descriptive
statistics
were
used
characterize
patient
population
outcomes;
statistical
analysis
performed
determine
association
variables
advanced
presentation.
Results
A
total
366
during
period.
median
age
48
(IQR
17–83).
majority
female
(60.1,
n
=
220),
single
(51.4%,
188),
29.2%
(
107)
endorsed
being
primary
provider
for
their
family.
number
dependents
per
4
2–50),
while
monthly
income
10269
Mexican
pesos
(MXN)
2000–13500]
travel
distance
INNN
49
km
22–174).
On
multivariate
analyses,
having
higher
increased
odds
presenting
longer
symptom
duration
p
0.01).
Divorced/separated
status
tumors
>
35mL
volume
0.04).
Primary
0.01)
average
0.03)
decreased
35mL.
Conclusions
This
is
first
recognize
that
certain
patients.
Further
studies
needed
order
decern
specific
causes
delayed
this
create
targeted
interventions
decrease
delays
care.